Advanced search
Publication Cover
Pharmaceutical Biology Volume 49, 2011 - Issue 3
Submit an article Journal homepage
655
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Depsides isolated from the Sri Lankan lichen Parmotrema sp. exhibit selective Plk1 inhibitory activity

David E. WilliamsDepartments of Chemistry and Earth & Ocean Sciences, University of British Columbia, Vancouver, British Columbia, Canada,
,
Frank LoganzoCenter for Integrative Biology and Biotherapeutics, Pfizer, Pearl River, New York, USA,
,
Lauren WhitneyCenter for Integrative Biology and Biotherapeutics, Pfizer, Pearl River, New York, USA,
,
Jenny TogiasScreening Sciences, Wyeth Research, Collegeville, Pennsylvania, USA,
,
Richard HarrisonScreening Sciences, Wyeth Research, Collegeville, Pennsylvania, USA,
,
Maya P. SinghNatural Products, Pfizer, Pearl River, New York, USA
,
Leonard A. McDonaldNatural Products, Pfizer, Pearl River, New York, USA
,
Selvaluxmy KathirgamanatharDepartment of Chemistry, University of Peradeniya, Peradeniya, Sri Lanka
,
Veranja KarunaratneDepartment of Chemistry, University of Peradeniya, Peradeniya, Sri Lanka
&
Raymond J. AndersenDepartments of Chemistry and Earth & Ocean Sciences, University of British Columbia, Vancouver, British Columbia, Canada,Correspondence[email protected]
 show all
Pages 296-301 | Received 25 Oct 2009, Accepted 18 Aug 2010, Published online: 01 Feb 2011

References

  • Barr FA, Silljé HH, Nigg EA. (2004). Polo-like kinases and the orchestration of cell division. Nat Rev Mol Cell Biol 5:429–440.
  • Blagden S, de Bono J. (2005). Drugging cell cycle kinases in cancer therapy. Curr Drug Targets 6:325–335.
  • Gray PJ Jr, Bearss DJ, Han H, Nagle R, Tsao MS, Dean N, Von Hoff DD. (2004). Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer. Mol Cancer Ther 3:641–646.
  • Jayaprakasha GK, Rao LJ. (2000). Phenolic constituents from the lichen Parmotrema stuppeum (Nyl.) Hale and their antioxidant activity. Z Naturforsch, C, J Biosci 55:1018–1022.
  • Jiang N, Wang X, Yang Y, Dai W. (2006). Advances in mitotic inhibitors for cancer treatment. Mini Rev Med Chem 6:885–895.
  • Knecht R, Elez R, Oechler M, Solbach C, von Ilberg C, Strebhardt K. (1999). Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. Cancer Res 59:2794–2797.
  • Krivoshchekova OE, Mishchenko NP, Stepanenko LS, Maksimov OB. (1983). Aromatic metabolites of Parmeliaceae lichens. I. Depsidones. Khimiya Prirodnykh Soedinenii 1:13–19.
  • Lansing TJ, McConnell RT, Duckett DR, Spehar GM, Knick VB, Hassler DF, Noro N, Furuta M, Emmitte KA, Gilmer TM, Mook RA Jr, Cheung M. (2007). In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1. Mol Cancer Ther 6:450–459.
  • Liu X, Erikson RL. (2003). Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc Natl Acad Sci USA 100:5789–5794.
  • Liu Y, Jiang N, Wu J, Dai W, Rosenblum JS. (2007). Polo-like kinases inhibited by wortmannin. Labeling site and downstream effects. J Biol Chem 282:2505–2511.
  • McInnes C, Mazumdar A, Mezna M, Meades C, Midgley C, Scaerou F, Carpenter L, Mackenzie M, Taylor P, Walkinshaw M, Fischer PM, Glover D. (2006). Inhibitors of polo-like kinase reveal roles in spindle-pole maintenance. Nat Chem Biol 2:608–617.
  • Mito K, Kashima K, Kikuchi H, Daa T, Nakayama I, Yokoyama S. (2005). Expression of polo-like kinase (PLK1) in non-Hodgkin’s lymphomas. Leuk Lymphoma 46:225–231.
  • Rangaswami S, Rao SV. (1955). Chemical components of Parmelia species of India. Indian J Pharm 7:50–53.
  • Smith MR, Wilson ML, Hamanaka R, Chase D, Kung H, Longo DL, Ferris DK. (1997). Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem Biophys Res Commun 234:397–405.
  • Spänkuch B, Matthess Y, Knecht R, Zimmer B, Kaufmann M, Strebhardt K. (2004). Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1. J Natl Cancer Inst 96:862–872.
  • Steegmaier M, Hoffmann M, Baum A, Lénárt P, Petronczki M, Krssák M, Gürtler U, Garin-Chesa P, Lieb S, Quant J, Grauert M, Adolf GR, Kraut N, Peters JM, Rettig WJ. (2007). BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo. Curr Biol 17:316–322.
  • Strebhardt K, Ullrich A. (2006). Targeting polo-like kinase 1 for cancer therapy. Nat Rev Cancer 6:321–330.
  • Takahashi T, Sano B, Nagata T, Kato H, Sugiyama Y, Kunieda K, Kimura M, Okano Y, Saji S. (2003). Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers. Cancer Sci 94:148–152.
  • Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R, Miyakawa I. (2001). Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage. Cancer Lett 164:41–49.
  • Weichert W, Schmidt M, Gekeler V, Denkert C, Stephan C, Jung K, Loening S, Dietel M, Kristiansen G. (2004). Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades. Prostate 60:240–245.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.